Projects per year
Personal profile
Research Interests
Biography
Craig Jamieson earned his BSc (Hons) in Chemistry at the University of Glasgow in 1996. His PhD studies were carried out under the direction of Professor R Ramage at the University of Edinburgh (1999). Following postdoctoral research under the supervision of Professor S V Ley at the University of Cambridge, in 2001 he was appointed as a Principal Scientist in GlaxoSmithKline's Discovery Medicinal Chemistry group working on a range of exploratory medicinal chemistry programmes. In 2004, Craig joined Organon Laboratories (later Merck Research Labs) as a Group Leader in the Medicinal Chemistry Department, with responsibility for hit to clincal candidate optimisation. In August 2010, Craig was appointed as a John Anderson Research Lecturer in Chemical Biology, based in the Department of Pure and Applied Chemistry at the University of Strathclyde where he is currently a Professor in the Chemical Biology and Medicinal Chemistry Research Theme.
Research Interests
A major area of focus for our research continues to be in the Chemistry-Biology-Medicine continuum. In this regard, we have a number of active programmes centred around hit and lead identification on disease targets and mechanisms in areas of significant societal need. Allied to our work in the medicinal chemistry sphere, we also have a keen interest in the development of novel, enabling synthetic methodologies to enhance the armamentarium of molecule makers working in our arena. We collaborate with groups and industrial partners locally, nationally and globally in order to effectively meet our research goals.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
AR-NTD Inhibitors as a Novel Treatment Modalityfor Castrate Resistant Prostate Cancer
Jamieson, C. (Principal Investigator)
MRC (Medical Research Council)
1/02/25 → 30/01/26
Project: Research
-
DTP 2224 University of Strathclyde | Schmid, Simon Paul
Jamieson, C. (Principal Investigator), Murphy, J. (Co-investigator) & Schmid, S. P. (Research Co-investigator)
EPSRC (Engineering and Physical Sciences Research Council)
1/10/24 → 1/04/28
Project: Research Studentship - Internally Allocated
-
eAmidation: an electrochemical amidation of aldehydes via the oxidation of N-aryl hydrazones
Chen, L., Thompson, J. D. F. & Jamieson, C., 12 Jun 2025, (E-pub ahead of print) In: Advanced Synthesis and Catalysis. 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Metabolic adaptations of micrometastases alter EV production to generate invasive microenvironments
Gounis, M., Campos, A. V., Shokry, E., Mitchell, L., Deshmukh, R., Dornier, E., Rooney, N., Dhayade, S., Pardo, L., Moore, M., Novo, D., Mowat, J., Jamieson, C., Kay, E., Zanivan, S., Paul, N. R., Mitchell, C., Nixon, C., Macpherson, I. & Tardito, S. & 4 others, , 9 Jun 2025, In: Journal of Cell Biology. 224, 8, 29 p., e202405061.Research output: Contribution to journal › Article › peer-review
Open AccessFile
Activities
-
Case Reference: CFS/2025/001
Reaney, L. (Consultant), Bame, J. (Consultant), Ceniccola-Campos, K. (Consultant), Anderson, G. (Consultant) & Jamieson, C. (Consultant)
Mar 2025 → Apr 2025Activity: Consultancy types › Consultancy
-
Sequence engineering to improve syringeability of high concentration mAb formulations
Armstrong, G. (Speaker), Rattray, Z. (Contributor), Casey, R. (Contributor), Lewis, W. (Contributor) & Jamieson, C. (Contributor)
23 Nov 2022Activity: Talk or presentation types › Oral presentation